Fingerprint
Dive into the research topics of 'Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients
Deepika Razia, Chengcheng Hu, Lauren Cherrier, Aasya Nasar, Rajat Walia, Sofya Tokman
Research output: Contribution to journal › Article › peer-review